179 related articles for article (PubMed ID: 10571943)
21. Mother-to-child transmitted WT1 splice-site mutation is responsible for distinct glomerular diseases.
Denamur E; Bocquet N; Mougenot B; Da Silva F; Martinat L; Loirat C; Elion J; Bensman A; Ronco PM
J Am Soc Nephrol; 1999 Oct; 10(10):2219-23. PubMed ID: 10505700
[TBL] [Abstract][Full Text] [Related]
22. New insights into the function of the Wilms tumor suppressor gene WT1 in podocytes.
Morrison AA; Viney RL; Saleem MA; Ladomery MR
Am J Physiol Renal Physiol; 2008 Jul; 295(1):F12-7. PubMed ID: 18385267
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome.
Schumacher V; Gueler B; Looijenga LH; Becker JU; Amann K; Engers R; Dotsch J; Stoop H; Schulz W; Royer-Pokora B
Mol Reprod Dev; 2008 Sep; 75(9):1484-94. PubMed ID: 18271004
[TBL] [Abstract][Full Text] [Related]
24. A review of the phenotypic variation due to the Denys-Drash syndrome-associated germline WT1 mutation R362X.
Heathcott RW; Morison IM; Gubler MC; Corbett R; Reeve AE
Hum Mutat; 2002 Apr; 19(4):462. PubMed ID: 11933209
[TBL] [Abstract][Full Text] [Related]
25. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function.
Guan LS; Liu JJ; Xu YH; Wang ZY
Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632
[TBL] [Abstract][Full Text] [Related]
26. Molecular heterogeneity and function of EWS-WT1 fusion transcripts in desmoplastic small round cell tumors.
Liu J; Nau MM; Yeh JC; Allegra CJ; Chu E; Wright JJ
Clin Cancer Res; 2000 Sep; 6(9):3522-9. PubMed ID: 10999739
[TBL] [Abstract][Full Text] [Related]
27. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
[TBL] [Abstract][Full Text] [Related]
28. Novel WT1 exon 9 mutation (D396Y) in a patient with early onset Denys Drash syndrome.
Little M; Carman G; Donaldson E
Hum Mutat; 2000 Apr; 15(4):389. PubMed ID: 10738002
[No Abstract] [Full Text] [Related]
29. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
Liu JJ; Wang ZY; Deuel TF; Xu YH
Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
[TBL] [Abstract][Full Text] [Related]
30. DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations.
Little M; Holmes G; Bickmore W; van Heyningen V; Hastie N; Wainwright B
Hum Mol Genet; 1995 Mar; 4(3):351-8. PubMed ID: 7795587
[TBL] [Abstract][Full Text] [Related]
31. Persistent Mullerian duct syndrome caused by both a 27-bp deletion and a novel splice mutation in the MIS type II receptor gene.
Hoshiya M; Christian BP; Cromie WJ; Kim H; Zhan Y; MacLaughlin DT; Donahoe PK
Birth Defects Res A Clin Mol Teratol; 2003 Oct; 67(10):868-74. PubMed ID: 14745940
[TBL] [Abstract][Full Text] [Related]
32. [WT1 mutation as a cause of progressive nephropathy in Frasier syndrome--case report].
Wasilewska A; Zoch-Zwierz W; Tenderenda E; Rybi-Szumińska A; Kołodziejczyk Z
Pol Merkur Lekarski; 2009 Jun; 26(156):642-4. PubMed ID: 19711733
[TBL] [Abstract][Full Text] [Related]
33. The role of Wilms' tumor genes.
Hirose M
J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
[TBL] [Abstract][Full Text] [Related]
34. Gonad development in Drash and Frasier syndromes depends on WT1 mutations.
Jaubert F; Vasiliu V; Patey-Mariaud de Serre N; Auber F; Jeanpierre C; Gubler MC; Nihoul-Fékété C; Fellous M
Arkh Patol; 2003; 65(2):40-4. PubMed ID: 15357247
[TBL] [Abstract][Full Text] [Related]
35. Clinical spectrum of Denys-Drash and Frasier syndrome.
McTaggart SJ; Algar E; Chow CW; Powell HR; Jones CL
Pediatr Nephrol; 2001 Apr; 16(4):335-9. PubMed ID: 11354777
[TBL] [Abstract][Full Text] [Related]
36. A female infant with Frasier syndrome showing splice site mutation in Wilms' tumor gene (WT1) intron 9.
Fujita S; Sugimoto K; Miyazawa T; Yanagida H; Tabata N; Okada M; Takemura T
Clin Nephrol; 2010 Jun; 73(6):487-91. PubMed ID: 20497763
[TBL] [Abstract][Full Text] [Related]
37. Analysis of possible WT1 RNA processing in primary Wilms tumors.
Gunning KB; Cohn SL; Tomlinson GE; Strong LC; Huff V
Oncogene; 1996 Sep; 13(6):1179-85. PubMed ID: 8808692
[TBL] [Abstract][Full Text] [Related]
38. WT1 mutations in patients with Denys-Drash syndrome: a novel mutation in exon 8 and paternal allele origin.
Nordenskjöld A; Friedman E; Anvret M
Hum Genet; 1994 Feb; 93(2):115-20. PubMed ID: 8112732
[TBL] [Abstract][Full Text] [Related]
39. WT1 splicing alterations in Wilms' tumors.
Baudry D; Hamelin M; Cabanis MO; Fournet JC; Tournade MF; Sarnacki S; Junien C; Jeanpierre C
Clin Cancer Res; 2000 Oct; 6(10):3957-65. PubMed ID: 11051244
[TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulation of PDGF-A and TGF-beta by +KTS WT1 deletion mutants and a mutant mimicking Denys-Drash syndrome.
Jin DK; Kang SJ; Kim SJ; Bang EH; Hwang HZ; Tadokoro K; Yamada M; Kohsaka T
Ren Fail; 1999 Nov; 21(6):685-94. PubMed ID: 10586431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
